Vicente LLP Psychedelics & Emerging Therapies Update: April 2024
Apr 12, 2024
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Apr 12, 2024
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Mar 28, 2024
Watch this pre-recorded session to learn about the future of intellectual property for cannabis and hemp products with rescheduling on the horizon. This webinar will feature a discussion with VLLP IP specialists regarding patent, IP and trademark protection, cannabis research, and what may change with potential federal marijuana rescheduling.
By Jason Adelstone
Mar 21, 2024
The International Narcotics Control Board (INCB) may be taking a more measured approach to cannabis. In their 2023 report, INCB used the word "may" when discussing potential inconsistencies between US state legalization and international treaties. This subtle shift in language suggests a more open-minded approach. This blog post explores the significance of this change in the report’s language and what it might mean for the future of global cannabis legalization.
By Jason Adelstone
Feb 27, 2024
Germany's recent enactment of a marijuana decriminalization bill marks a significant development in European drug policy. While falling short of full legalization, the new law allows for decriminalized possession, home cultivation, and participation in cannabis clubs. This blog post provides a concise overview of the new legislation, its potential impact, and its wider implications for the evolving European cannabis landscape.
By Jason Adelstone
Jan 30, 2024
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.
Dec 19, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
By Jason Adelstone
Dec 7, 2023
On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic mushrooms” from Schedule I to Schedule II. Read this Insights post for more information about the Ninth Circuit Court’s order to reschedule psilocybin.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Oct 11, 2023
Watch this live session on Wednesday, October 11 at 1 p.m. ET. The session will feature Vicente LLP’s director of economics and research, Andrew Livingston, and the firm’s Michigan practice leader, Travis Copenhaver, as they discuss Michigan cannabis market trends and opportunities that will help your business to better adapt, strategize, and navigate changing market conditions.
Oct 4, 2023
Watch this special briefing where Vicente LLP leaders share insights on the impacts of the HHS recommendation to reschedule cannabis and outline the road ahead.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Sep 11, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Jul 7, 2023
Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.
Apr 19, 2023
Watch this Vicente LLP session for insights on current CRA enforcement trends and best practices for running a compliant cannabis business in Michigan.
By Krissy Atterholt
Mar 30, 2023
Regulatory enforcement against Michigan cannabis licensees has increased significantly since mid-2022. Read this article for a breakdown of the number of actions, types of penalties, and categories of non-compliance resulting in enforcement.
By Jason Adelstone
Mar 15, 2023
In its 2022 report, the International Narcotics Control Board (INCB) argues that legalizing the non-medical and non-scientific use of cannabis has failed to achieve the benefits to society that were intended through such legalization. In its attempt to deliver evidence of this failure, INCB instead provides ample evidence to the contrary—that legalization and regulation work. Read this insight for Vicente LLP’s response to the annual report of the INCB.
Mar 9, 2023
Join Vicente partner Travis Copenhaver and Michigan cannabis dispensary owner Mario Porter during a Rootwurks webinar on March 15 to learn the latest compliance and regulatory tips that come with running a cannabis company in Michigan.
By Cassia Furman, Jason Adelstone
Feb 24, 2023
A bill passed in 2022 authorized California to enter into agreements with neighboring states allowing for interstate transfers between cannabis licensees, so long as the cannabis products don’t pass through a non-legal state. Could this be implemented? What are the risks?
By Krissy Atterholt
Feb 14, 2023
Michigan leads the Midwest in affording its communities local protection for psychedelic-based activities. This article gives a breakdown of notable moments in Michigan's psychedelic legislative history.
Dec 23, 2022
On January 7, 2023, the VS team will provide legal services at a drug conviction record sealing clinic in Denver, Colorado.
Dec 8, 2022
Watch this session on-demand for a discussion on the cannabis landscape and emerging opportunities in Michigan, Minnesota, Illinois, Ohio, North Dakota, South Dakota, and Wisconsin.
By Krissy Atterholt
Oct 28, 2022
Complying with Michigan's marijuana packaging and labeling laws can be challenging to navigate if you don't pay close attention to the rules. If a product's packaging is not compliant, some potential remedies are available to bring the product back into compliance.
By Krissy Atterholt
Oct 28, 2022
Cannabis packaging and labeling requirements vary across markets and product types, so it’s critical that your packaging and labeling are compliant with state-specific regulations. Read this article to know what information needs to be on marijuana product packaging in Michigan.
By Travis Copenhaver
Jul 29, 2022
Michigan cannabis licensing is broken up into three steps: prequalification, municipal approval, and state facility approval. The first major hurdle every licensee must go through is the prequalification process.
By Jason Adelstone
Apr 27, 2022
A recent paper by Kenzi Riboulet-Zemouli argues that the 1961 Single Convention on Narcotic Drugs already allows for the regulation of Non-Medical cannabis. This premise, unfortunately, is just incorrect.
By Travis Copenhaver
Mar 24, 2022
Michigan's MRA recently announced the Class A Marihuana Microbusiness License. This new microbusiness license differs from the original in several interesting ways, which may create a more profitable business model.
Jul 22, 2021
VS's Jason Adelstone, Catie Wightman and Genevieve Meehan will participate in a free expungement clinic to be held on July 31, 2021 in Denver.
By Vicente Sederberg LLP
May 24, 2021
Read the memo VS delivered to the International Narcotics Control Board, which gives draft guidelines on control requirements for medical and scientific cannabis and discusses the implications and important issues for consideration.
Mar 29, 2021
Vicente Sederberg is monitoring local, state, and federal responses to the coronavirus (COVID-19) and how they may impact cannabis businesses, service providers, and consumers.
By Jerrico Perez and Jason Adelstone
Oct 29, 2020
On November 3, 2020, Arizona voters will again vote to legalize an adult-use marijuana program, four years after rejecting a similar initiative.
By Jerrico Perez
Aug 21, 2020
Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.
By Sahar Ayinehsazian and Kelsey Middleton
May 28, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on cannabis businesses, service providers, and consumers in Michigan.
By Jerrico Perez
May 13, 2020
Vicente Sedeberberg LLP continues to identify exclusive licensing opportunities for our clients. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience can help elevate your application above the competition.
Mar 9, 2020
You received your Michigan cannabis license. Now what? Join VS and Cannabis Legal Group on March 25 to learn about how to take your business to the next level with private financing.
May 8, 2019
Barton Morris, of counsel at Vicente Sederberg and founder of Cannabis Legal Group, VS's strategic partner in Michigan, was selected to be a member of Attorney General Dana Nessel's marijuana legal workgroup.